Cargando…

Case report of prostate ductal adenocarcinoma presenting with hematuria

Detalles Bibliográficos
Autores principales:	Pawlowski, Jamie, Swanson, Gregory P., Mahalingam, Devalingam, Ha, Chul S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5991314/ https://www.ncbi.nlm.nih.gov/pubmed/29888196 http://dx.doi.org/10.1016/j.eucr.2018.05.013

Ejemplares similares

Case report: Recurrent urethral polyps, an atypical presentation of ductal prostate adenocarcinoma
por: Holmes, Angela, et al.
Publicado: (2022)

Ductal Adenocarcinoma of the Prostate With a Rare Clinical Presentation; Late Gastric Metastasis
por: Tavukcu, Hasan Huseyin, et al.
Publicado: (2016)

Multifocal primary amyloidosis of the bladder presenting with gross hematuria: A case report and review of literature
por: Kalathia, Jaisukh, et al.
Publicado: (2023)

Local recurrence of prostatic ductal adenocarcinoma despite clear surgical margins
por: Merrett, Christopher, et al.
Publicado: (2018)

Ductal Adenocarcinoma of the Prostate: A Case Report
por: Hayashi, Yutaro, et al.
Publicado: (2016)

Metastasis of Duodenal Adenocarcinoma to the Urinary Bladder Presenting as Hematuria
por: Tulsi, Rani, et al.
Publicado: (2021)

Recurrent hematuria: A rare presentation of leiomyosarcoma of the prostate
por: Loghmari, Ahmed, et al.
Publicado: (2022)

Efficacy of dabrafenib/trametinib in pancreatic ductal adenocarcinoma with BRAF NVTAP deletion: A case report
por: Shin, Ji Eun, et al.
Publicado: (2022)

Novel Management of Anastomotic Disruption and Persistent Hematuria Following Robotic Prostatectomy: Case Report and Review of the Literature
por: Paul, Charles J., et al.
Publicado: (2017)

Targeting mTOR in Pancreatic Ductal Adenocarcinoma
por: Iriana, Sentia, et al.
Publicado: (2016)

Non-coding RNAs in Pancreatic Ductal Adenocarcinoma
por: Gong, Ruining, et al.
Publicado: (2020)

Prognostic Biomarkers for Pancreatic Ductal Adenocarcinoma: An Umbrella Review
por: Wang, Yizhi, et al.
Publicado: (2020)

Biological Significance of YAP/TAZ in Pancreatic Ductal Adenocarcinoma
por: Hayashi, Hiromitsu, et al.
Publicado: (2021)

Pancreatic Ductal Adenocarcinoma Cortical Mechanics and Clinical Implications
por: Angstadt, Shantel, et al.
Publicado: (2022)

The immunoregulation effect of tumor microenvironment in pancreatic ductal adenocarcinoma
por: Zhang, Jingchang, et al.
Publicado: (2022)

Gross hematuria as the presentation of an inguinoscrotal hernia: a case report
por: Ansari, Kayvan, et al.
Publicado: (2011)

Genetic Tracing of Clonal Expansion and Progression of Pancreatic Ductal Adenocarcinoma: A Case Report and Multi-Region Sequencing Analysis
por: Tachibana, Shion, et al.
Publicado: (2020)

Biochemical Predictors of Response to Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma
por: Awad, Seifeldin, et al.
Publicado: (2020)

Hyperdense Pancreatic Ductal Adenocarcinoma: Clinical Characteristics and Proteomic Landscape
por: Xu, He, et al.
Publicado: (2021)

The Role of Stellate Cells in Pancreatic Ductal Adenocarcinoma: Targeting Perspectives
por: Wu, Yang, et al.
Publicado: (2021)

Serum Biomarker Panel for Diagnosis and Prognosis of Pancreatic Ductal Adenocarcinomas
por: Mehta, Shreya, et al.
Publicado: (2021)

A rare case of ductal variant multilocular prostatic cystadenocarcinoma invading the rectum
por: Talluri, Sriharsha, et al.
Publicado: (2023)

Clear cell adenocarcinoma of the prostatic urethra with metachronous prostate adenocarcinoma
por: Wang, Henry, et al.
Publicado: (2023)

Vascularization, Oxygenation, and the Effect of Sunitinib Treatment in Pancreatic Ductal Adenocarcinoma Xenografts
por: Gaustad, Jon-Vidar, et al.
Publicado: (2019)

Relevance of Immune Infiltration and Clinical Outcomes in Pancreatic Ductal Adenocarcinoma Subtypes
por: Liu, Rong, et al.
Publicado: (2021)

The Current Treatment Paradigm for Pancreatic Ductal Adenocarcinoma and Barriers to Therapeutic Efficacy
por: Principe, Daniel R., et al.
Publicado: (2021)

Corrigendum: Serum Biomarker Panel for Diagnosis and Prognosis of Pancreatic Ductal Adenocarcinomas
por: Mehta, Shreya, et al.
Publicado: (2021)

Systematic Characterization of the Clinical Relevance of KPNA4 in Pancreatic Ductal Adenocarcinoma
por: Bao, Jingpiao, et al.
Publicado: (2022)

Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma: Where Do We Go?
por: Wang, Chenqi, et al.
Publicado: (2022)

Development and validation of an MRI-radiomics nomogram for the prognosis of pancreatic ductal adenocarcinoma
por: Xu, Xinsen, et al.
Publicado: (2023)

Digital quantitative tissue image analysis of hypoxia in resected pancreatic ductal adenocarcinomas
por: Siddiqui, Iram, et al.
Publicado: (2022)

Loss of Cadherin-11 in pancreatic ductal adenocarcinoma alters tumor-immune microenvironment
por: Sebastian, Aimy, et al.
Publicado: (2023)

Case Report: Lung Adenocarcinoma Initially Presenting With Cutaneous and Subcutaneous Metastases
por: Wang, Jingjing, et al.
Publicado: (2022)

Hematuria: An Unusual Presentation for Mucocele of the Appendix. Case Report and Review of the Literature
por: Oliphant, Uretz J., et al.
Publicado: (1999)

Chloroma of the Bladder: A Case Report of Leukemia Progression Presenting as Hematuria
por: Pearson, Laurie K., et al.
Publicado: (2021)

An Atypical Case of Bladder Lipoma Presenting as Gross Hematuria: A Case Report
por: Kaltsas, Aris, et al.
Publicado: (2023)

An incidentally diagnosed prostatic ductal adenocarcinoma
por: Stajno, Paweł, et al.
Publicado: (2013)

MRI Finding of Prostatic Ductal Adenocarcinoma
por: Kitajima, Kazuhiro, et al.
Publicado: (2021)

Regulation of Proliferation by a Mitochondrial Potassium Channel in Pancreatic Ductal Adenocarcinoma Cells
por: Peruzzo, Roberta, et al.
Publicado: (2017)

Circulating Chromogranin A Is Cleaved Into Vasoregulatory Fragments in Patients With Pancreatic Ductal Adenocarcinoma
por: Reni, Michele, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nqeq2ibmas98qm5djimo7pt247